China Isotope & Radiation Corporation (1763.HK)

HKD 10.4

(-2.07%)

Revenue Summary of China Isotope & Radiation Corporation

  • China Isotope & Radiation Corporation's latest annual revenue in 2023 was 6.63 Billion CNY , up 7.95% from previous year.
  • China Isotope & Radiation Corporation's latest quarterly revenue in 2024 Q2 was 2.81 Billion CNY , down 0.0% from previous quarter.
  • China Isotope & Radiation Corporation reported a annual revenue of 6.14 Billion CNY in annual revenue 2022, up 19.49% from previous year.
  • China Isotope & Radiation Corporation reported a annual revenue of 5.14 Billion CNY in annual revenue 2021, up 20.34% from previous year.
  • China Isotope & Radiation Corporation reported a quarterly revenue of 6.63 Billion CNY for 2023 FY, up 7.95% from previous quarter.
  • China Isotope & Radiation Corporation reported a quarterly revenue of 3.89 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of China Isotope & Radiation Corporation (2023 - 2015)

Historical Annual Revenue of China Isotope & Radiation Corporation (2023 - 2015)

Year Revenue Revenue Growth
2023 6.63 Billion CNY 7.95%
2022 6.14 Billion CNY 19.49%
2021 5.14 Billion CNY 20.34%
2020 4.27 Billion CNY 7.15%
2019 3.98 Billion CNY 23.19%
2018 3.23 Billion CNY 21.18%
2017 2.67 Billion CNY 13.07%
2016 2.36 Billion CNY 9.8%
2015 2.15 Billion CNY 0.0%

Peer Revenue Comparison of China Isotope & Radiation Corporation

Name Revenue Revenue Difference
Vincent Medical Holdings Limited 717.97 Million HKD -824.128%